Table 1.
Tumor | Stroke | |
---|---|---|
N | 196 | 147 |
Sex (%) | ||
Male | 128 (65.3) | 99 (67.3) |
Female | 68 (34.7) | 48 (32.7) |
Mean age (SD) | 50.9 (14.1) | 57.4 (12.9) |
Range | 21–81 | 19–82 |
Mean educational level (SD)a | 5.4 (1.3) | 5.3 (1.3) |
Hand preference (%)b | ||
Left | 26 (13.3) | 18 (12.2) |
Right | 163 (83.2) | 125 (85.0) |
Ambidexter | 1 (0.5) | 2 (1.4) |
Unknown | 6 (3.1) | 2 (1.4) |
WHO 2016 classification (%) | N.A. | |
II + III astrocytoma IDH-M | 55 (28.1) | |
II + III astrocytoma IDH-WT | 12 (6.1) | |
II + III oligodendroglioma IDM-M 1p19q | 38 (19.4) | |
IV glioblastoma IDH-M | 4 (2.0) | |
IV glioblastoma IDH-WT | 72 (36.7) | |
Unknown | 15 (7.7) | |
Median lesion volume in cm3 (SD) | 66.5 (71.9) | 5.8 (27.1) |
Range | 1.2–349.1 | 0.1–233.2 |
Lesion location (%) | ||
Left | 117 (59.7) | 66 (44.9) |
Right | 65 (33.2) | 66 (44.9) |
Bilateral | 14 (7.1) | 15 (10.2) |
Group differences in clinical characteristics were tested with a Pearson χ2 test or Kruskal-Wallis test when appropriate. Significant difference (p < 0.05) are shown in bold.
aEducational level was assessed using the Verhage criteria (1964).
bHand preference was self-reported.